Screener
Janux Therapeutics JANX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 41,957 | 45,118 | 79,903 | 80,015 |
| Loss from operations | (31,690) | (45,118) | (65,903) | (80,015) |
| Other income: | ||||
| Interest income | 9,718 | 11,260 | 19,570 | 22,649 |
| Total other income | 9,718 | 11,260 | 19,570 | 22,649 |
| Net loss | $(21,972) | $(33,858) | $(46,333) | $(57,366) |
| Other comprehensive gain (loss): | ||||
| Unrealized gain (loss) on available-for-sale securities, net | (2,881) | (9) | (6,621) | 1,584 |
Item 1. Financial Statements.
FAQ
- What is Janux Therapeutics's interest income?
- Janux Therapeutics (JANX) reported interest income of $9.72M in Q2 2026.
- How has Janux Therapeutics's interest income changed year-over-year?
- Janux Therapeutics's interest income decreased by 13.7% year-over-year, from $11.26M to $9.72M.
- What is the long-term trend for Janux Therapeutics's interest income?
- Over 4 years (2021 to 2025), Janux Therapeutics's interest income has grown at a 261.8% compound annual growth rate (CAGR), from $257K to $44.04M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Janux Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude